Atherosclerosis: Risk factors and the vascular endothelium

American Heart Journal

Volumn 131, Issue 2, 1996, Pages 379-384

  Glasser, Stephen P ^a   Selwyn, Andrew P ^b   Ganz, Peter ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ATHEROSCLEROSIS; BLOOD VESSEL COMPLIANCE; CIGARETTE SMOKING; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; HYPERTENSION; MENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0030063352     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90370-1     Document Type: Article

References (56)

1. Anderson TJ, Meredith IT, Ganz P, Selwyn AP, Yeung AC. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol 1994;24:555-66.
2. Furchgott RF. The discovery of endothelium-dependent relaxation. Circulation 1993;87(suppl):V3-V8.
3. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
4. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-37.
5. Michel T, Smith TW. Nitric oxide synthases and cardiovascular signaling. Am J Cardiol 1993;72:33C-8C.
6. Morris JJ. Mechanisms of ischemia in coronary artery disease: spontaneous decrease in coronary blood supply. AM HEART J 1990;120:746-56.
7. Lüscher TF, Diederich D, Siebenmann R, Lehmann K, Stultz P, von Segesser L, Yang Z, Turina M, Grädel E, Weber E, Bühler F. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 1988;319:462-7.
8. Arbustini E, Grasso M, Diegoli M, Bellini O, Ghio S, DeServi S, Martinelli L, Vigano M, Specchia G. Morphologic changes induced by acetylcholine infusion in normal and atherosclerotic coronary arteries. Am J Cardiol 1993;71:1382-90.
9. Chesebro JH, Fuster V, Webster MWI. Endothelial injury and coronary vasomotion. J Am Coll Cardiol 1989;14:1191-2.
10. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1990;16:349-56.
11. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol 1994;23:844-50.
12. Reddy KG, Nair RN, Sheehan HM, Hodgson JMcB. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994;23:833-43.
13. Simon BC, Cunningham LD, Cohen RA. Oxidized low-density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990;86:75-9.
14. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;334:160-2.
15. Anderson TJ, Meredith MB, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endotheliumdependent coronary vasomotion. N Engl J Med 1995;332:488-93.
16. Dyce MC, Anderson TJ, Yeung AC, Ganz P, Lieberman EH, Gerhard MD, Selwyn AP, Meredith IT. Indices of LDL particle size closely relate to endothelial function [Abstract]. Circulation 1993;88(suppl I):466.
17. Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation 1993;87:1461-7.
18. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995;75:1B-5B.
19. El-Tamimi H, Mansour M, Wargovich TJ, Hill JA, Kerensky JA, Conti R, Pepine CJ. Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Circulation 1994;89:45-51.
20. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-64.
21. Benzuly KH, Padgett RC, Kaul S, Piegors BS, Armstrong ML, Heistad DD. Functional improvement precedes structural regression of atherosclerosis. Circulation 1994;89:1810-18.
22. Superko HR, Krauss RM. Coronary artery disease regression: convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994;90:1056-69.
23. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987;80:1808-11.
24. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992;85:1927-38.
25. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993;341:1496-1500.
26. Treasure CB, Klein L, Weitraub WS, Talley D, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-7.
27. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, Ganz P, Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993;87:86-93.
28. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993;87:1475-81.
29. Lüscher TF, Vanhoutte PM, Rau L. Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension 1987;9(suppl):III193-III197.
30. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endotheliumderived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-74.
31. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993;21:1145-51.
32. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for the release of EDRF in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-7.
33. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993;88:77-81.
34. Cohn JN, Finkelstein SM. Abnormalities of vascular compliance in hypertension, aging and heart failure. J Hypertens 1992;10(suppl):S61-4.
35. Uehata A, Gerhard MD, Meredith IT, Lieberman EL, Selwyn AP, Creager M, Polak J, Ganz P, Yeung AC, Anderson TJ. Close relationship of endothelial dysfunction in coronary and brachial artery [Abstract]. Circulation 1993;88(suppl I):618.
36. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994;24:471-6.
37. Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 1985;37:529-33.
38. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with doserelated and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88(part 1):2149-55.
39. Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, Bühler F. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994;90:27-34.
40. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994;89:1501-10.
41. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452-7.
42. Williams JK, Shively CA, Clarkson TB. Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis. Circulation 1994;90:983-7.
43. Collins P, Shay J, Jiang C, Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 1994;90:1964-8.
44. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung A, Creager M. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-41.
45. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 1993;87(suppl):V67-V76.
46. Dubois-Randé JL, Zelinsky R, Roudot F, Chabrier PE, Castaigne A, Geschwind H, Adnot S. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Am J Cardiol 1992;70:1269-75.
47. Hamon M, Vallet B, Bauters C, Wernert N, McFadden E, LaBlanche J-M, Dupuis B, Bertrand ME. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendotheliumdependent acetylcholine-induced relaxation after arterial injury. Circulation 1994;90:1357-62.
48. Mehta JL, Yang BC, Nichols WW. Free radicals, antioxidants, and coronary artery disease. J Myocardial Ischemia 1993;5:31-41.
49. Gilligan DM, Sack MN, Guetta V, Casino PR, Quyyumi AA, Rader DJ, Panza JA, Cannon RO. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 1994;24:1611-7.
50. Zhao G, Zhang X, Xu X, Hintze T. Enhanced NO production from coronary microvessels in racing greyhounds. Part of the genetic engineering of exercise. Abstracts of the Scientific Conference on the Functional and Structural Aspects of the Vascular Wall 1995; Feb:143.
51. Kingwell BA, Tran B, Jennings GL, Dart AM. Endothelium dependent vasorelaxation is enhanced in athletes. Abstracts of the Scientific Conference on the Functional and Structural Aspects of the Vascular Wall 1995; Feb:149.
52. Cameron JD, Dart AM. Exercise training increases total systemic compliance in humans. Am J Physiol 1994;266:693-701.
53. Vaitkevicius PV, Fleg JL, Engel JH, O'Conner FC, Wright JG, Lakatta LE, Yin FC, Lakatta EG. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993;88:1456-62.
54. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epid 1994;140:669-82.
55. McVeigh GE, Burns DE, Finkelstein SM, McDonald KM, Mock JE, Feske W, Carlyle PF, Flack J, Grimm R, Cohn JN. Reduced vascular compliance as a marker for essential hypertension. Am J Hypertens 1991;4:245-51.
56. Franklin SS, Weber MA. Measuring hypertensive cardiovascular risk: the vascular overload concept. AM HEART J 1994;128:793-803.